Randomized, double-blind, placebo-controlled clinical trial to evaluate the efficacy and safety of Lacticaseibacillus rhamnosus CRL1505 in the prevention of upper respiratory tract infections in a healthy pediatric population

FilesOpen
Identifiers
URI: http://hdl.handle.net/10952/8970



Statistics
View Usage Statistics
Metadata
Show full item record
Date
2024-12
Discipline/s
Ciencias de la Alimentación
Medicina
Subject/s
Prevention
Upper respiratory tract infections
Probiotics
Microbiota
Microbiome
Abstract
Randomized, double-blind, placebo-controlled, parallel-group, clinical trial to assess the efficacy of the intake of a probiotic product composed of Lacticaseibacillus rhamnosus CRL1505 strain in reducing or preventing upper respiratory tract infections (URTIs) in a healthy pediatric population.
Collections
Attribution-NonCommercial-NoDerivatives 4.0 Internacional
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internacional